drugset / Trial / NCT00592176

The Effect of Bevacizumab (Avastin) on Pterygium

NCT00592176 ↗

Phase 2 Completed 5 enrolled University of Alabama at Birmingham
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether local injection of bevacizumab might halt and or cause regression of pterygium growth. This may enable earlier treatment and prevention of pterygium growth into the patient's line of sight thereby limiting the need for surgery and improving quality of life for patients with pterygia.

Timeline

Start
2007-08
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 2.5 mg Other